Cellular Senescence in Livers from Children with End Stage Liver Disease by Gutierrez-Reyes, Gabriela et al.
Cellular Senescence in Livers from Children with End
Stage Liver Disease
Gabriela Gutierrez-Reyes
1., Maria del Carmen Garcia de Leon
1., Gustavo Varela-Fascinetto
2, Pedro
Valencia
2, Ruy Pe ´rez Tamayo
1, Claudia Gonzalez Rosado
1, Blanca Farfan Labonne
1, Norma Morales
Rochilin
1, Rosalinda Martinez Garcia
1, Jonathan Aguirre Valadez
1, Gabriela Togno Latour
1, Dana Lau
Corona
1, Guillermo Robles Diaz
1, Albert Zlotnik
3, David Kershenobich
1*
1Department of Experimental Medicine, School of Medicine, Universidad Nacional Auto ´noma de Me ´xico (UNAM), Mexico City, Mexico, 2Department of Surgery and
Pathology, Hospital Infantil de Me ´xico Federico Gomez, Mexico City, Mexico, 3University of California Irvine, Irvine, California, United States of America
Abstract
Background: Senescent cells occur in adults with cirrhotic livers independent of the etiology. Aim: Investigate the presence
rate of cellular senescence and expression of cell cycle check points in livers from children with end stage disease.
Methodology/Principal Findings: Livers of five children aged three years or less undergoing liver transplantation due to
tyrosinemia (n=1), biliary atresia (n=2), or fulminant hepatitis (n=2) were analyzed for senescence associated b-
galactosidase (SA-bgal) activity and p16INK4a, p21cip1 and p53. All livers displayed positive cellular staining for SA-bgal in
the canals of Hering and interlobular biliary ducts. In the presence of cirrhosis (3/5 cases) SA-bgal was found at the
cholangioles and hepatocytes surrounding the regenerative nodules. Children with fulminant hepatic failure without
cirrhosis had significant ductular transformation with intense SA-bgal activity. No SA-bgal activity was evident in the fibrous
septa. Staining for p53 had a similar distribution to that observed for SA-bgal. Staining for p16
INK4a and p21
cip1 was positive
in the explanted liver of the patient with tyrosinemia, in the hepatocytes, the canals of Hering, cholangioles and interlobular
bile ducts. In the livers with fulminant hepatitis, p21
cip1 staining occurred in the areas of ductular transformation and in the
interlobular bile ducts.
Conclusions/Significance: Cellular senescence in livers of children with end stage disease is associated with damage rather
than corresponding to an age dependent phenomenon. Further studies are needed to support the hypothesis that these
senescence markers correlate with disease progression.
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Introduction
In contrast to other types of cellular responses such as necrosis
or apoptosis, the role of cellular senescence in the living organism
is still not well understood. Senescence was originally described in
human fibroblasts as a terminal non dividing stage reached after
many cell divisions in cultures [1]Senescent cells remain alive,
metabolically active and resistant to apoptotic death but are
arrested in the G1 phase of the cell cycle, are resistant to growth
factor stimulation and show common biochemical markers, such
as expression of an SA-bgal enzyme [2–3]. While senescence has
been characterized primarily in cultured cells, there is also
evidence that it occurs in vivo [4–6].
An increase in liver cells staining positive for SA-bgal has been
demonstrated in adults with cirrhotic livers independent of the
etiology, including chronic viral hepatitis, autoimmune liver
disease, primary biliary cirrhosis and chronic alcoholic liver
disease; in these situations, chronic liver damage has been related
to oxidative stress or telomere shortening, eventually culminating
in replicative senescence [6–9]. Senescence has also been
described to be associated to the progression of fibrosis in hepatitis
C virus recurrence after liver transplantation, where a correlation
has been observed between ischemic necrosis and replicative
senescence on the revascularization biopsy, suggesting that livers
containing senescent cells may be more sensitive to ischemia [10].
The genes associated with senescence have for the most part
been tumor suppressor genes believed to be involved in the
underlying mechanisms of replicative and stress-induced senes-
cence [11–15]. p53 functions as a central integration point for
various signaling pathways of senescence and inhibits cell division
primarily through a p21
cip1 pathway [16–18]. The phosphorylated
p53 upregulates transcription of the target gene p21
cip1, which in
turn activates pRb through inhibition of a cyclin-dependent kinase
(Cdk) complex [19]. The activated pRb inhibits the transcription
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Another Cdk inhibitor, p16
INK4a, which also activates pRb,
accumulates in senescent cells and is considered essential in stress-
induced senescence [13,14,20,21,22].
In this study, we report the presence of senescence biomarkers,
including SA-bgal activity and the expression of p53, p21
cip1, and
p16
INK4a, in liver from children with end stage liver disease that
required transplantation.
Results
Analysis of the explanted livers
The liver of the patient with cirrhosis secondary to tyrosinemia
(case 1) exhibited, on cut sections, multiple nodules that varied in
size from 0.2 to 2.0 cm. The hepatocytes differed in size and
shape, their cytoplasm contained lipid droplets, granular material
and numerous mitochondria. Some had a dysplastic appearance
with atypical nuclei. Fibrous septa of variable size were present;
these hepatocytes had a variable immunohistochemical expression
of nuclear proliferation factors and fetoproteins (data not shown).
The dysplastic hepatocytes were not present in the initial
diagnostic biopsy performed two years ago.
In the patients with extrahepatic biliary atresia (cases 2, 3)
histology revealed the presence of micronodular cirrhosis. Active
fibro-inflammatory septa with cholangiolar proliferation, mild
lymphocytic infiltrate and cholestasis were found in case 2, while
fibrous septa without bile ducts were observed in case 3. When
compared with the initial diagnostic biopsies, the explanted livers
of the two patients showed that fibrosis had progressed and both
had the typical changes of biliary cirrhosis.
In the children with fulminant hepatic failure (cases 4, 5) the
liver had severe gross deformation, large areas of necrosis that
were intermingled with nodules of residual hepatic parenchyma;
huge necrotic zones were observed exhibiting a dense inflamma-
tory infiltrate composed mainly of mononuclear cells. Immuno-
histochemical studies revealed, in case 4, a predominant B cell
response with equal number of Kappa and Lambda cells, while in
case 5 the cellular infiltrate was predominantly composed of T
lymphocytes (CD3, CD45RO; data not shown).
Both livers exhibited significant ductular transformation.
SA-bgal activity
SA-bgal activity was detected in all five explanted livers. Its
amount and distribution were heterogeneous. In all cases, staining
was present in the canals of Hering and interlobular biliary ducts
(TABLE 1). In the children with liver cirrhosis additional staining
occurred in the cholangioles, and hepatocytes surrounding the
regenerative nodules (Fig. 1A–B). In the livers of children with
fulminant hepatic failure, intense staining was observed in the
areas of ductal transformation (Fig. 1C). No SA-bgal activity was
evident in the fibrous septa. In the livers of the five normal donors
(with normal histology) SA-b gal activity was not detected.
p53
p53 staining had a similar distribution to that observed for SA-
bgal activity, but was less common among the structures
(TABLE 2). In the cirrhotic livers (Fig. 1D and F) p53 staining
was found in the canals of Hering, interlobular bile ducts and the
hepatocytes in the regenerative nodules. In the patients with
fulminant hepatitis p53 was also found in the ductular transfor-
mation areas (Fig. 1E).
p16
INK4a and p21
cip1
Staining for p16
INK4a and p21
cip1 was positive in the explanted
liver of the patient with tyrosinemia in the hepatocytes, the canals
of Hering, cholangioles and interlobular bile ducts (Fig. 1G–H) In
the livers with fulminant hepatitis, p21
cip1 staining occurred in the
areas of ductal transformation and in the interlobular bile ducts
(Fig. 1I; TABLE 2).
Discussion
Cellular senescence is usually considered an attribute of aging.
Its presence in livers of young children with end stage hepatic
disease, characterized by SA- bgal activity accompanied by
changes in the classical senescence pathway encompassing
activation of p53, p21
cip1 and p16
INK4a, as found in the present
study, support the concept that the loss of replicative capacity of
the hepatocytes is related to liver damage.
Senescence markers were found for the most part in the Hering
canals and the interlobular biliary ductules independent of the
etiology of the underlying disease. All five children had an
increased number of senescent cells accompanied with the
expression of p53, reinforcing the concept of p53 as the major
initiator of the senescence and a key regulator of DNA damage
responses.
In the three cases with liver cirrhosis, the senescent hepatocytes
were found predominantly around the regenerative nodules or
inside of them (in lesser proportion) and absent in the fibrous
septa. This distribution is similar to patterns previously described
in adults [6]. In the two children with fulminant hepatic failure,
senescent cells were displayed mainly at the site of the ductular
Table 1. SA-bgal expression in the liver of children with end stage hepatic disease (%).
Patient Nodule Hepatocytes
Canals of
Hering
Ductular
Transformation
Interlobular
bile ducts Cholangioles
Central Periphery
1 5 10 100 NO 100 100
2 30 50 60 NO 100 60
3 Neg 20 10 NO NO 10
4 Col Col 100 90 100 neg
5 neg neg 100 50 100 NO
Col=collapsed.
NO=not observed.
neg=negative.
doi:10.1371/journal.pone.0010231.t001
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atypical ductular reaction observed in livers with sub-massive
hepatitis represents the proliferation of hepatic progenitor cells,
similar to rat oval cells and are able to differentiate towards the
biliary and the hepatocytic lineage [23–24]. Whether the ductular
reaction observed in this study in the two children with fulminant
hepatic failure represents an activated stem cell response or biliary
metaplasia of cholestatic injured hepatocytes is not clear. When we
used an antibody directed to CK7 (as a marker of biliary
epithelium), approximately 60% of the staining was present in the
tubular structures and all the staining was found in cells located in
the canals of Hering (data not shown). The latter represent the
anatomic and physiologic link between the intralobular canalicular
system and the terminal branches of the biliary tree, suggesting
that hepatocytes could have differentiated into biliary cells that
aggregate to form the ductular structures [25] Transplantation of
rat hepatocytes into a syngeneic rat spleen results in the
appearance of CK 7 positive biliary cells that form ductules
[26]. p21 is recognized as a valuable check point for evaluating
proliferative activity/proliferation arrest of hepatocytes. In the
case of fulminant hepatitis were more than 50% of hepatocytes
where lost, p21 was found to be expressed in the ductular area
Figure 1. Representative images of senescence associated marker (b-galactosidase) and cell cycle markers (p16
INK4a, p21
cip1 and
p53). SA-bgal expression (turquoise blue) in fresh liver sections of the recipients with end stage liver disease. (A–B) Intense SA-bgal in canals of
Hering (cH), interlobular bile ducts (bd) and cholangioles (ch) in a patient with biliary atresia. (case 2) Magnification: 206,6 0 6. (C) Ductular
transformation of hepatocytes (dt) exhibiting SA-bgal in a patient with fulminant hepatic failure (case 4). Magnification: 406. (D–I) Nuclear staining in
formalin fixed paraffin embedded livers with end stage liver disease. (D) p53 canals of Hering (cH) and interlobular bile ducts (bd) in a patient with
biliary atresia (case 3). (E) Canals of Hering (cH), interlobular bile ducts (bd) and hepatocyte ductular transformation (dt) in a patient with acute liver
failure (case 4). (F) Hepatocytes in the regenerative nodules (h) and in the bile duct in the fibrotic bands (bd) in a patient with tyrosinemia (case 1),
Magnification: 406. (G) p16
INK4a staining in the hepatocytes (h) inside a regenerative nodule (case 1). Magnification: 206, (H) p21
cip1, staining in bile
duct (bd) in the fibrotic bands and in the hepatocytes (h) inside a regenerative nodule (case 1). Magnification: 406. (I) p21
cip1 staining in the nuclei of
cells that aggregate to form ductular transformation structures (dt) (case 4). Magnification 406.
doi:10.1371/journal.pone.0010231.g001
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time to activate indicating disease severity. On the other hand the
upregulated expression of p21 in the hepatocytes located in the
regenerative nodules and its periphary in the case of tyrosinemia
suggest the inhibition of cell proliferation and advance necrosis.
Overall, our findings point towards the equilibrium in the
control of self-renewal and multilineage differentiation capacities
of regenerative cells. For once the decline in the regenerative
capacity and changes in number of functional stem/progenitor
cells which at the same time may increase the risk to develop
associated diseases and on the other the accumulation of genetic
alterations leading to changes in regulation of numerous tumor
suppressor genes. These processes in term could become be more
relevant if deregulated signals from an aged niche, so as those of a
small admixture of non dividing senescent cells could contribute to
their dysfunctions or loss, which could account for some of the
observed differences in time (chronic vs acute) of the patients
herein reported. In order to further support the hypothesis that
these senescence markers correlate with disease progression, it will
be necessary to design studies including disease and age matched
controls and to explore in more detail the possible mechanisms
involved.
Methods
Patients
The study includes 5 consecutive patients aged three years or
less with end stage liver disease due to tyrosinemia (n=1) biliary
atresia (n=2) fulminant hepatitis (n=2) who underwent liver
transplantation at Mexico City’s Children’s Hospital (Hospital
Infantil de Mexico). Complete clinical charts and pre-transplant
liver biopsies were available for each case. The patients with liver
cirrhosis due to tyrosinemia and biliary atresia had evidence of
liver disease from the early days after being born. The patients
with acute liver failure, one corresponded to an autoimmune
etiology of seven months of progression with 30 days of acute liver
failure and the other had nine days of disease progression of
unknown etiology. The two patients with biliary atresia and liver
cirrhosis had portal hypertension and esophageal bleeding. The
two patients with acute liver failure have severe encephalopathy.
Three patients received a liver allograft from living relatives and
two from deceased donors. The surgical procedure and sample
collections were described in detail to the patients’ parents and
appropriate signed informed consent was obtained. The study was
approved by the institutional review board of the Hospital Infantil
de Mexico.
Explanted liver analyses
Sections from formalin fixed paraffin-embedded liver tissue
were stained with haematoxylin and eosin, Masson’s trichrome,
PAS, PAS-diastase, modified orcein, reticulin Perl’s iron, immu-
nohistochemistry and special staining when necessary.
SA-bgal Activity
Fresh tissue samples were used to detect activity of b-
galactosidase at pH of 6.0 as marker of senescence. Surgical
specimens were frozen immediately in OCT, cut into 5-mm
sections and fixed with glutaraldehyde at 0.2% for 10 minutes.
After washing with lacZ at room temperature the specimens
were stained for 14–18 hrs at 37uC with fresh galactosidase
staining solution. The solution contained 1 mg/ml 5-bromo-4-
chloro-3-indolyl-b-D-galactoside (X-gal) (Sigma-Aldrich, St Louis,
MO, USA). After staining, the specimens were washed twice with
PBS. The specimens were counterstained with hematoxilin
staining solution for one minute and washed twice in PBS. The
cells with SA-bgal activity showed a blue turquoise staining in
the cytoplasm.
Immunohistochemistry
Deparaffinized tissue was microwave heated to retrieve antigen
and reacted with full-length monoclonal antibodies to p53 (Sigma-
Aldrich, St Louis, MO, USA) at a dilution of 1:50, p21
cip1 at a dilution
of 1:25 and p16
INK4a at a dilution of 1:75, (Santa Cruz Biotechnology,
Santa Cruz, CA) and incubated at 4uC overnight. A secondary
antibody coupled with alkaline phosphatase was used to expose the
reaction to the monoclonal antibodies; NBT/BCIP substrate was
used as a chromogen. Carcinomatous colon tissue served as
positive controls. Negative control slides were reacted with a non
related antibody to Aspergillus niger (Dako Cytomation, Glostrup,
Denmark) under similar conditions. Percentage of positive nuclear
staining either weak or strong was noted. Quantification was
performed by manual counting on 10 representative fields by two
independent observers and photographed with a Nikon Micro-
phot-FXA microscope. The mean of the scores counted by each of
the observers was used as expression score.
An indirect immunohistochemical technique was utilized to
stain for CK7 (Dako Cytomation, Glostrup, Denmark), employing a
Table 2. Expression of senescence markers in the liver of children with end stage hepatic disease (%).
Patient Nodule Hepatocytes
Canals
of Hering
Ductular
Transformation
Interlobular
bile ducts Cholangioles
Central Periphery
p16 p21 p53 p16 p21 p53 p16 p21 p53 p16 p21 p53 p16 p21 p53 p16 p21 p53
1 85 80 75 85 80 75 100 100 70 NO NO NO 35 100 15 100 100 Neg
2 neg neg neg neg neg 10 neg neg 30 NO NO NO neg neg 30 neg neg 50
3 neg neg 20 neg neg 50 neg neg 60 NO NO NO neg neg 30 neg NO 30
4 Col Col Col Col Col Col 100 neg 30 30 50 80 30 20 30 neg neg 50
5 Col Col Col Col Col Col neg neg .10 50 neg 80 100 20 30 NO NO NO
Col=collapsed.
NO=not observed.
neg=negative.
doi:10.1371/journal.pone.0010231.t002
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as a chromogen.
Acknowledgments
The authors thank Marco Gudin ˜o for his help in histological imaging and
Leticia Sanchez for her assistance.
Author Contributions
Conceived and designed the experiments: GGR MdCGdL GRD AZ DK.
Performed the experiments: MdCGdL CGR NMR RMG JAV GTL DLC.
Analyzed the data: GGR MdCGdL GVF PV RPT DK. Contributed
reagents/materials/analysis tools: GVF PV. Wrote the paper: GGR
MdCGdL DK. Performed some of the experiments: BFL.
References
1. Hayflick L, Moorhead PS (1961) The serial cultivation of human diploid cell
strains. Exp Cell Res 25: 585–621.
2. Dimri GP, Lee X, Basile G, Acosta M, Scott G, et al. (1995) A biomarker that
identifies senescent human cells in culture and in aging skin in vivo. Proc Natl
Acad Sci USA 92: 9363–9367.
3. Maier A, Westendorp R, Van Heemst D (2007) Beta-galactosidase activity as a
biomarker of replicative senescence during the course of human fibroblast
cultures. Ann N Y Acad Sci 1100: 323–32.
4. Zhang H (2007) Molecular signaling and genetic pathways of senescence: Its role
in tumorigenesis and aging. J Cell Physiol 210: 567–574.
5. Campisi J (2000) Cancer, aging and cellular senescence. In Vivo 14: 183–188.
6. Paradis V, Youssef N, Darge `re D, Ba ˆ N, Bonvoust F, et al. (2001) Replicative
senescence in normal liver, chronic hepatitis C and hepatocellular carcinomas.
Hum Pathol 32: 327–332.
7. Wiemann SU, Satyanarayana A, Tsahuridu M, Tillmann HL, Zender L, et al.
(2002) Hepatocyte telomere shortening and senescence are general markers of
human liver cirrhosis. FASEB J 16: 935–942.
8. Shawi M, Autexier C (2008) Telomerase,senescence and ageing. Mech Ageing
Dev 129: 3–10.
9. Passos JF, Saretzki G, von Zglinicki T (2007) DNA damage in telomeres and
mitochondria during cellular senescence: is there a connection? Nucleic Acids
Res 35: 7505–7513.
10. Trak-Smayra V, Contreras J, Dondero F, Durand F, Dubois S, et al. (2004) Role
of replicative senescence in the progression of fibrosis in hepatitis C virus (HCV)
recurrence after liver transplantation. Transplantation 77: 1755–1760.
11. Kiss A, Schnur J, Szabo ´ Z, Nagy P (2001) Immunohistochemical analysis of
atypical ductular reaction in the human liver, with special emphasis on the
presence of growth factors and their receptors. Liver 21: 237–246.
12. Seki S, Kitada T, Sakaguchi H, Iwai S, Kawada N, et al. (2003) Expression of
progenitor cell markers in livers with fulminant massive necrosis. Hepatol Res
25: 149–157.
13. Martien S, Abbadie C (2007) Acquisition of oxidative DNA damage during
senescence: the first step toward carcinogenesis? Ann N Y Acad Sci 1119: 51–63.
14. Chen JH, Ozanne SE, Hales CN (2007) Methods of cellular senescence
induction using oxidative stress. Methods Mol Biol 371: 179–189.
15. Courtois-Cox S, Jones SL, Cichowski K (2008) Many roads lead to oncogene-
induced senescence. Oncogene 27: 2801–2809.
16. Yang S, Koteish A, Lin H, Huang J, Roskams T, et al. (2004) Oval cells
compensate for damage and replicative senescence of mature hepatocytes in
mice with fatty liver disease. Hepatology 39: 403–411.
17. Obata M, Imamura E, Yoshida Y, Goto J, Kishibe K, et al. (2001) Resistance of
primary cultured mouse hepatic tumor cells to cellular senescence despite
expression of p16(Ink4a), p19
(Arf), p53 and p21
(Waf 1/Cip1). Mol Carcinog 32:
9–18.
18. Chen J, Huang X, Halicka D, Brodsky S, Avram A, et al. (2006) Contribution of
p16INK4a and p21CIP1 pathways to induction of premature senescence of
human endothelial cells: permissive role of p53. Am J Physiol Heart Circ Physiol
290: H1575–H1586.
19. Kuhlmann WD, Peschke P (2006) Hepatic progenitor cells, stem cells and AFP
expression in models of liver injury. Int J Exp Pathol 87: 343–359.
20. Watanabe H, Hata M, Terada N, Ueda H, Yamada N, et al. (2008)
Transdifferentiation into biliary ductular cells of hepatocytes transplanted into
the spleen. Pathology 40: 272–276.
21. Bringold F, Serrano M (2000) Tumor suppressors and oncogenes in cellular
senescence. Exp Gerontol 35: 317–329.
22. Takahashi A, Ohtani N, Yamakoshi K, Iida S, Tahara H, et al. (2006) Mitogenic
signaling and the p16
INK4a-Rb pathway cooperate to enforce irreversible cellular
senescence. Nat Cell Biol 8: 1291–1297.
23. Kenyon J, Gerson SL (2007) The role of DNA damage repair in aging of adult
stem cells. Nucleic Acids Res 35: 7557–7565.
24. Ju YJ, Lee KH, Park JE, Yi YS, Yun MY, et al. (2006) Decreased expression of
DNA repair proteins Ku70 and Mre11 is associated with aging and may
contribute to the cellular senescence. Exp Mol Med 38: 686–693.
25. Prieur A, Peeper DS (2008) Cellular senescence in vivo: a barrier to
tumorigenesis. Curr Opin Cell Biol 20: 150–155.
26. Zwerschke W, Mazurek S, Sto ¨ckl P, Hu ¨tter E, Eigenbrodt E, et al. (2003)
Metabolic analysis of senescent human fibroblasts reveals a role for AMP in
cellular senescence. Biochem J 376: 403–411.
Senescence and Liver Disease
PLoS ONE | www.plosone.org 5 April 2010 | Volume 5 | Issue 4 | e10231